EastPharma reported sales results for the nine months of 2015. For the period, the company reported revenue of USD 158.3 million, up 1.1% from USD 156.6 million for the same period in 2014. Sales increase in US Dollar terms was mainly due to increased volumes in Human Pharma products business.
1st Jan change | Capi. | |
---|---|---|
+19.62% | 42.97B | |
+24.52% | 22.49B | |
+20.29% | 14.93B | |
+7.48% | 13.14B | |
+42.51% | 11.67B | |
-8.84% | 6.86B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.54B |